Key takeaway from this morning's session at #ASCO25 - Adoption of PSMA PET-CT scans in high-risk localised prostate cancer is outpacing the evidence.

The @prostatecanceruk.bsky.social funded AVIDITY trial is looking to fill this evidence gap.

prostatecanceruk.org/about-us/new...

Promising results presented at #ASCO25 for the SYNC-T therapeutic vaccine. One to keep an eye on as it progresses into larger trials